Related Experiment Videos
Viral measurement by polymerase chain reaction-based assays in human immunodeficiency virus-infected infants
P E Palumbo1, S Kwok, S Waters
1Department of Pediatrics, University of Medicine and Dentistry of New Jersey-New Jersey Medical School, Newark 07103, USA.
Insights
Infants with human immunodeficiency virus (HIV) show high viral loads and low immune response in their first year. Early intervention is supported by findings, even before symptoms appear.
Area of Science:
- Pediatrics
- Virology
- Immunology
Background:
- Human immunodeficiency virus (HIV) infection in infants presents unique challenges.
- Understanding early viral dynamics is crucial for effective management.
- Assessing immune response in early childhood HIV is vital.
Purpose of the Study:
- To analyze viral load and immune markers in HIV-infected infants.
- To investigate the relationship between viral replication and immune status.
- To evaluate the potential for early intervention strategies.
Main Methods:
- Serial plasma samples from HIV-infected infants were collected.
- Quantitative human immunodeficiency virus polymerase chain reaction (HIV-PCR) assays were performed.
- CD4 lymphocyte counts were monitored.
Main Results:
- High, persistent levels of plasma HIV RNA and proviral DNA were detected.
- An effective immune response appeared to be absent in most infants.
- Normal CD4 counts and absence of symptoms were observed for 3-6 months despite high viral replication.
Conclusions:
- Early HIV infection in infants is characterized by significant viral replication.
- The findings support the evaluation of early intervention before symptom onset.
- Quantitative HIV assays may have predictive value for disease progression.
Abstract:
Serial samples from human immunodeficiency virus-infected infants in the first year of life were analyzed by quantitative human immunodeficiency virus polymerase chain reaction assays. Very high, persistent levels of plasma RNA and proviral DNA were detected throughout the study period, suggesting the absence of an effective immune response. Most patients had normal CD4 lymphocyte counts and were symptom free for the first 3 to 6 months despite high levels of viral replication. These findings support the evaluation of early intervention (before symptoms develop) and efforts to establish the predictive value of these assays.